# Equilibre BioPharmaceuticals Corp. — Form D

Equilibre BioPharmaceuticals Corp. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-20. The offering totals $25.0M, of which $15.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-01-20
- Form: D
- Accession: 0000947871-22-000085
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $15.9M
- Remaining: $9.1M
- Investors: 14
- Date of first sale: 2022-01-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-430166

## Issuer

- Name: Equilibre BioPharmaceuticals Corp.
- CIK: 0001831900
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 430 E 29th St., NEW YORK, NY, 10016
- Phone: 332-400-0300

## Officers, directors & promoters (20)

| Name | Role | Location |
| --- | --- | --- |
| Philip Barach | Director | Portland, ME |
| David Friedman | Director | NEW HAVEN, CT |
| Steven Gordon | Director | New York, NY |
| Francois Maisonrouge | Director | New York, NY |
| Joel Marcus | Director | South San Francisco, CA |
| Peter Simon | Director | Denver, CO |
| Samuel Waksal | Director | New York, NY |
| Steven Gordon | Executive Officer | New York, NY |
| Samuel Waksal | Executive Officer | New York, NY |
| Christopher M Thorn | Director | New York, NY |
| Christopher M Thorn | Executive Officer | New York, NY |
| Christina A Ramirez | Director | New York, NY |
| Peter M Simon | Director | New York, NY |
| Francois A Maisonrouge | Director | New York, NY |
| Sam Waksal | Executive Officer | New York, NY |
| DAVID A FRIEDMAN | Director | EVANSTON, IL |
| Steven N Gordon | Director | New York, NY |
| Steven N Gordon | Executive Officer | New York, NY |
| PHILIP A BARACH | Director | LOS ANGELES, CA |
| PHILIP A BARACH | Executive Officer | LOS ANGELES, CA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-12-01](https://search.stillhousedata.com/formd/0001831900-22-000001) | D | $6.0M | $6.0M |
| [2022-12-01](https://search.stillhousedata.com/formd/0001831900-22-000002) | D/A | $6.0M | $6.0M |
| [2020-11-12](https://search.stillhousedata.com/formd/0001831900-20-000001) | D | $35.8M | $25.8M |

## More

- [CIK 1831900 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1831900&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000947871-22-000085.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.